Search - tctmd.com

Displaying 1 - 20 of 29

Sort: Relevancy | Date

News Conference News EuroPCR 2019

Ultrathin Struts Show Strength in Small Vessels: BIO-RESORT at 3 Years

Caitlin E. Cox

May 21, 2019

Presentation EuroPCR 2019

3-year clinical outcome following treatment with thin, very thin or ultrathin strut drug-eluting stents in small coronary vessels in BIO-RESORT

Presenter: Clemens von Birgelen

May 21, 2019

Podcast TCTMD Talking Points

BIONYX: A Thin Composite-Wire Strut, Durable Polymer-Based DES Compared With an Ultrathin-Strut Bioresorbable Polymer-Based DES in an All-Comers Patient Population

February 20, 2019

News Opinion Editor's Corner TCT 2018

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

Shelley Wood

September 22, 2018

News Conference News CRT 2018

Wait Continues for a Win With Biodegradable-Polymer DES in Patients at High Bleeding Risk: BIO-RESORT

Michael O'Riordan

March 08, 2018

Presentation EuroPCR 2017

BIO-RESORT Silent Diabetes

Presenter: Clemens von Birgelen

May 19, 2017

News Conference News EuroPCR 2017

Transradial PCI in ACS Reduces Risk of Acute Kidney Injury

Michael O'Riordan

May 18, 2017

News Conference News EuroPCR 2017

BIO-RESORT: Impaired Glucose Metabolism Linked With Worse Clinical Outcomes After PCI

Michael O'Riordan

May 18, 2017

News Daily News

TWENTE: Resolute and Xience Stents Show Comparable Outcomes up to 5 Years

Michael O'Riordan

January 20, 2017

News Conference News TCT 2016

DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term

Todd Neale

October 30, 2016

Presentation TCT 2016

BIO-RESORT (TWENTE III): A Prospective, Randomized Three-Arm Trial Comparing Two Different Biodegradable Polymer-Based Drug-Eluting Stents and a Durable Polymer-Based Drug-Eluting Stent in an All-Comers Population of Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Wayne B. Batchelor, Clemens von Birgelen

October 30, 2016

News Conference News TCT 2015

TWENTE: ZES, EES Convey Similar Safety, Efficacy Results at 5 Years

October 14, 2015

News Daily News

TWENTE: Second-Generation DES Show Good Long-term Outcomes in Bifurcation Lesions

L.A. McKeown

November 02, 2014

News Daily News

TWENTE: los SLF de 2ª Generación tienen Buenos Resultados a Largo Plazo en Lesiones en Bifurcación

L.A. McKeown

November 02, 2014

News Daily News

TWENTE：第二代DES在分叉病变中表现出良好的长期结果

L.A. McKeown

November 02, 2014

Presentation TCT 2014

2-Year Clinical Outcome of the Randomized, Multicenter DUTCH PEERS (TWENTE II) Trial, Comparing Cobalt-Chromium Zotarolimus-Eluting Resolute Integrity Stents and Platinum-Chromi___

Presenter: Clemens von Birgelen

September 16, 2014

News Daily News

DUTCH PEERS Published: Third-Generation Zotarolimus, Everolimus Stents Equivalent

February 12, 2014

News Daily News

DUTCH PEERS Publicado: Los Stents liberadores de Zotarolimus y Everolimus de 3ª Generación son Equivalentes

February 12, 2014

Presentation

Third-Gen ZES and EES in All-Comers Patients Requiring PCI: DUTCH PEERS Noninferiority Trial

Presenter: Clemens von Birgelen

February 09, 2014

Presentation TCT 2013

DUTCH PEERS (TWENTE II): A Prospective, Randomized, "All-Comers" Trial of Third-Generation Zotarolimus-Eluting Stents vs. Everolimus-Eluting Coronary Stents

Presenter: Clemens von Birgelen

October 31, 2013

Advertisement

Ultrathin Struts Show Strength in Small Vessels: BIO-RESORT at 3 Years

3-year clinical outcome following treatment with thin, very thin or ultrathin strut drug-eluting stents in small coronary vessels in BIO-RESORT

BIONYX: A Thin Composite-Wire Strut, Durable Polymer-Based DES Compared With an Ultrathin-Strut Bioresorbable Polymer-Based DES in an All-Comers Patient Population

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

Wait Continues for a Win With Biodegradable-Polymer DES in Patients at High Bleeding Risk: BIO-RESORT

BIO-RESORT Silent Diabetes

Transradial PCI in ACS Reduces Risk of Acute Kidney Injury

BIO-RESORT: Impaired Glucose Metabolism Linked With Worse Clinical Outcomes After PCI

TWENTE: Resolute and Xience Stents Show Comparable Outcomes up to 5 Years

DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term

BIO-RESORT (TWENTE III): A Prospective, Randomized Three-Arm Trial Comparing Two Different Biodegradable Polymer-Based Drug-Eluting Stents and a Durable Polymer-Based Drug-Eluting Stent in an All-Comers Population of Patients With Coronary Artery Disease

TWENTE: ZES, EES Convey Similar Safety, Efficacy Results at 5 Years

TWENTE: Second-Generation DES Show Good Long-term Outcomes in Bifurcation Lesions

TWENTE: los SLF de 2ª Generación tienen Buenos Resultados a Largo Plazo en Lesiones en Bifurcación

TWENTE：第二代DES在分叉病变中表现出良好的长期结果

2-Year Clinical Outcome of the Randomized, Multicenter DUTCH PEERS (TWENTE II) Trial, Comparing Cobalt-Chromium Zotarolimus-Eluting Resolute Integrity Stents and Platinum-Chromi___

DUTCH PEERS Published: Third-Generation Zotarolimus, Everolimus Stents Equivalent

DUTCH PEERS Publicado: Los Stents liberadores de Zotarolimus y Everolimus de 3ª Generación son Equivalentes

Third-Gen ZES and EES in All-Comers Patients Requiring PCI: DUTCH PEERS Noninferiority Trial

DUTCH PEERS (TWENTE II): A Prospective, Randomized, "All-Comers" Trial of Third-Generation Zotarolimus-Eluting Stents vs. Everolimus-Eluting Coronary Stents

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content